167 related articles for article (PubMed ID: 37055321)
1. Independent human mesenchymal stromal cell-derived extracellular vesicle preparations differentially attenuate symptoms in an advanced murine graft-versus-host disease model.
Madel RJ; Börger V; Dittrich R; Bremer M; Tertel T; Phuong NNT; Baba HA; Kordelas L; Staubach S; Stein F; Haberkant P; Hackl M; Grillari R; Grillari J; Buer J; Horn PA; Westendorf AM; Brandau S; Kirschning CJ; Giebel B
Cytotherapy; 2023 Aug; 25(8):821-836. PubMed ID: 37055321
[TBL] [Abstract][Full Text] [Related]
2. CD73 activity of mesenchymal stromal cell-derived extracellular vesicle preparations is detergent-resistant and does not correlate with immunomodulatory capabilities.
Bauer FN; Tertel T; Stambouli O; Wang C; Dittrich R; Staubach S; Börger V; Hermann DM; Brandau S; Giebel B
Cytotherapy; 2023 Feb; 25(2):138-147. PubMed ID: 36244910
[TBL] [Abstract][Full Text] [Related]
3. Qualification of a multidonor mixed lymphocyte reaction assay for the functional characterization of immunomodulatory extracellular vesicles.
Bremer M; Nardi Bauer F; Tertel T; Dittrich R; Horn PA; Börger V; Giebel B
Cytotherapy; 2023 Aug; 25(8):847-857. PubMed ID: 37097266
[TBL] [Abstract][Full Text] [Related]
4. Individual Immune-Modulatory Capabilities of MSC-Derived Extracellular Vesicle (EV) Preparations and Recipient-Dependent Responsiveness.
Kordelas L; Schwich E; Dittrich R; Horn PA; Beelen DW; Börger V; Giebel B; Rebmann V
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987036
[TBL] [Abstract][Full Text] [Related]
5. Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease.
Dal Collo G; Adamo A; Gatti A; Tamellini E; Bazzoni R; Takam Kamga P; Tecchio C; Quaglia FM; Krampera M
Stem Cells; 2020 May; 38(5):698-711. PubMed ID: 32064745
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.
Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN
Front Immunol; 2018; 9():2538. PubMed ID: 30473695
[TBL] [Abstract][Full Text] [Related]
7. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations.
Fujii S; Miura Y; Fujishiro A; Shindo T; Shimazu Y; Hirai H; Tahara H; Takaori-Kondo A; Ichinohe T; Maekawa T
Stem Cells; 2018 Mar; 36(3):434-445. PubMed ID: 29239062
[TBL] [Abstract][Full Text] [Related]
8. Scaled Isolation of Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles.
Börger V; Staubach S; Dittrich R; Stambouli O; Giebel B
Curr Protoc Stem Cell Biol; 2020 Dec; 55(1):e128. PubMed ID: 32956560
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory and Regenerative Effects of MSC-Derived Extracellular Vesicles to Treat Acute GVHD.
Fujii S; Miura Y
Stem Cells; 2022 Nov; 40(11):977-990. PubMed ID: 35930478
[TBL] [Abstract][Full Text] [Related]
10. Imaging flow cytometry challenges the usefulness of classically used extracellular vesicle labeling dyes and qualifies the novel dye Exoria for the labeling of mesenchymal stromal cell-extracellular vesicle preparations.
Tertel T; Schoppet M; Stambouli O; Al-Jipouri A; James PF; Giebel B
Cytotherapy; 2022 Jun; 24(6):619-628. PubMed ID: 35314115
[TBL] [Abstract][Full Text] [Related]
11. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
[TBL] [Abstract][Full Text] [Related]
12. Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles.
Gimona M; Brizzi MF; Choo ABH; Dominici M; Davidson SM; Grillari J; Hermann DM; Hill AF; de Kleijn D; Lai RC; Lai CP; Lim R; Monguió-Tortajada M; Muraca M; Ochiya T; Ortiz LA; Toh WS; Yi YW; Witwer KW; Giebel B; Lim SK
Cytotherapy; 2021 May; 23(5):373-380. PubMed ID: 33934807
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Studies of MSC-Derived Extracellular Vesicles to Treat or Prevent Graft Versus Host Disease: a Systematic Review of the Literature.
Gupta M; Tieu A; Slobodian M; Shorr R; Burger D; Lalu MM; Allan DS
Stem Cell Rev Rep; 2021 Apr; 17(2):332-340. PubMed ID: 33159616
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.
Ossendorff R; Grad S; Tertel T; Wirtz DC; Giebel B; Börger V; Schildberg FA
Front Immunol; 2023; 14():1198198. PubMed ID: 37564645
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic prospects of MicroRNAs carried by mesenchymal stem cells-derived extracellular vesicles in autoimmune diseases.
Liu H; Chen Y; Yin G; Xie Q
Life Sci; 2021 Jul; 277():119458. PubMed ID: 33831424
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model.
Khatri M; Richardson LA; Meulia T
Stem Cell Res Ther; 2018 Jan; 9(1):17. PubMed ID: 29378639
[TBL] [Abstract][Full Text] [Related]
17. A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles.
Pachler K; Lener T; Streif D; Dunai ZA; Desgeorges A; Feichtner M; Öller M; Schallmoser K; Rohde E; Gimona M
Cytotherapy; 2017 Apr; 19(4):458-472. PubMed ID: 28188071
[TBL] [Abstract][Full Text] [Related]
18. [Research Progress on Immunomodulatory Activity and Clinical Application of Mesenchymal Stem Cells-Derived Extracellular Vesicles--Review].
Zhao J; Jiang Y; Hao SG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):955-958. PubMed ID: 35680833
[TBL] [Abstract][Full Text] [Related]
19. Proteomics profile of mesenchymal stromal cells and extracellular vesicles in normoxic and hypoxic conditions.
Braga CL; da Silva LR; Santos RT; de Carvalho LRP; Mandacaru SC; de Oliveira Trugilho MR; Rocco PRM; Cruz FF; Silva PL
Cytotherapy; 2022 Dec; 24(12):1211-1224. PubMed ID: 36192337
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.
Doeppner TR; Herz J; Görgens A; Schlechter J; Ludwig AK; Radtke S; de Miroschedji K; Horn PA; Giebel B; Hermann DM
Stem Cells Transl Med; 2015 Oct; 4(10):1131-43. PubMed ID: 26339036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
